Trupanion (TRUP) Projected to Post Earnings on Thursday

Trupanion (NASDAQ:TRUP) is expected to be issuing its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $375.8920 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 12, 2026 at 4:30 PM ET.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, November 6th. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.76). The firm had revenue of $366.92 million during the quarter, compared to analyst estimates of $361.58 million. Trupanion had a return on equity of 4.48% and a net margin of 1.10%.The company’s revenue was up 12.0% on a year-over-year basis. During the same quarter last year, the company posted $0.03 EPS. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Trupanion Stock Performance

Shares of TRUP stock opened at $32.34 on Thursday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.31. Trupanion has a 12-month low of $30.54 and a 12-month high of $57.88. The business’s 50 day moving average is $35.36 and its two-hundred day moving average is $40.90. The company has a market capitalization of $1.40 billion, a P/E ratio of 89.84 and a beta of 1.58.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on TRUP. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, December 29th. Cantor Fitzgerald reduced their price objective on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research report on Wednesday, January 14th. Stifel Nicolaus dropped their target price on shares of Trupanion from $42.00 to $38.00 and set a “hold” rating on the stock in a research report on Thursday, January 29th. Wall Street Zen cut shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Finally, Piper Sandler decreased their price target on shares of Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, December 19th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and an average price target of $50.00.

Insider Activity

In other news, CFO Fawwad Qureshi sold 6,202 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total value of $219,860.90. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO John R. Gallagher sold 6,383 shares of the company’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $34.82, for a total transaction of $222,256.06. Following the sale, the chief operating officer directly owned 32,721 shares of the company’s stock, valued at approximately $1,139,345.22. This represents a 16.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,853 shares of company stock worth $1,181,863 over the last three months. Insiders own 5.42% of the company’s stock.

Institutional Trading of Trupanion

Several hedge funds have recently made changes to their positions in the company. Royal Bank of Canada increased its holdings in shares of Trupanion by 60.6% during the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after buying an additional 11,233 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Trupanion by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after acquiring an additional 858 shares during the period. Millennium Management LLC increased its stake in Trupanion by 73.5% during the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after acquiring an additional 113,490 shares during the last quarter. Invesco Ltd. increased its stake in Trupanion by 35.1% during the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after acquiring an additional 48,781 shares during the last quarter. Finally, Gabelli Funds LLC purchased a new stake in Trupanion in the second quarter valued at $249,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.